ANDREW Q PHAM

Allopathic & Osteopathic Physicians|Internal Medicine LOS ANGELES, CA NPI 1659609527

General Payments — all program years on this page

$5,244.67

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 165
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $696.15 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $696.1521

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $247.273
2019 $330.1611
2020 $100.424
2021 $1,076.8240
2022 $1,400.6441
2023 $1,393.2145
2024 $696.1521

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1099894199 ALK-Abello, Inc $16.60 01/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1099894201 ALK-Abello, Inc $20.82 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105256206 ABBVIE INC. $22.18 03/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105306174 AstraZeneca Pharmaceuticals LP $119.73 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111676185 Amgen Inc. $20.40 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111676187 Amgen Inc. $16.43 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111676189 Amgen Inc. $23.43 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111676191 Amgen Inc. $17.72 06/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114136842 Regeneron Healthcare Solutions, Inc. $28.06 02/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114136844 Regeneron Healthcare Solutions, Inc. $32.14 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114136846 Regeneron Healthcare Solutions, Inc. $20.81 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114136848 Regeneron Healthcare Solutions, Inc. $15.20 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114136850 Regeneron Healthcare Solutions, Inc. $34.84 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114136852 Regeneron Healthcare Solutions, Inc. $120.01 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116031167 GlaxoSmithKline, LLC. $27.30 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116154604 GlaxoSmithKline, LLC. $29.99 05/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116310487 GlaxoSmithKline, LLC. $27.23 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116382572 GlaxoSmithKline, LLC. $30.50 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116416796 GlaxoSmithKline, LLC. $24.22 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124732643 Grifols USA, LLC $15.00 04/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137653844 Takeda Pharmaceuticals U.S.A., Inc. $33.54 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.